Back to today’s briefing

Story perspectives

Stanford's Discovery Revives Hope for Parkinson's Treatment

7/2/2025

43 9

Summary

Story summary

A groundbreaking discovery at Stanford University offers hope for Parkinson's disease patients. Researchers found that the MLi-2 kinase inhibitor, targeting the LRRK2 genetic mutation, rejuvenates neuron communication by regrowing primary cilia. This innovative approach not only promises to improve Parkinson's treatment but also holds potential for other neurodegenerative disorders, with clinical trials already in progress.

1 of 1

Story summary

A groundbreaking discovery at Stanford University offers hope for Parkinson's disease patients. Researchers found that the MLi-2 kinase inhibitor, targeting the LRRK2 genetic mutation, rejuvenates neuron communication by regrowing primary cilia. This innovative approach not only promises to improve Parkinson's treatment but also holds potential for other neurodegenerative disorders, with clinical trials already in progress.